Kaliumchlorid Noridem

Potassium chloride, the active ingredient in Kaliumchlorid Noridem, is a potassium supplement presented as an intravenous solution for IV use. It treats hypokalemia and potassium deficiency by restoring normal serum potassium levels in patients who require electrolyte correction.

GNH USA supplies Kaliumchlorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumchlorid Noridem, a potassium supplement, is used to correct electrolyte imbalances associated with low serum potassium.

- Hypokalemia: restores serum potassium to the normal range, supporting muscle and nerve function. - Potassium deficiency: replenishes intracellular potassium stores to maintain cellular electrophysiology. - Cardiac arrhythmia risk due to low potassium: helps stabilize cardiac membrane potential and reduce arrhythmic events.

Intravenous potassium chloride can be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Infusion site pain or irritation: mild discomfort at the injection site. - Nausea: transient feeling of sickness. - Vomiting: occasional emesis during or after infusion. - Muscle weakness: temporary reduction in muscle strength. - Tingling or paresthesia: sensation of pins and needles. - Hyperkalemia (mild): modest rise in serum potassium above the target range.

Serious or Rare Side Effects: - Severe hyperkalemia: marked elevation of serum potassium that can cause cardiac arrest. - Cardiac arrhythmias: life‑threatening rhythm disturbances. - Anaphylactic reaction: rare hypersensitivity with airway compromise. - Thrombophlebitis: inflammation and clot formation in the vein. - Death: extremely rare but reported in cases of uncontrolled hyperkalemia.

When using Kaliumchlorid Noridem, several precautions should be observed to ensure patient safety.

- Monitor serum potassium: check levels before, during, and after infusion. - Adjust dose in renal impairment: reduce infusion rate or total dose in patients with reduced kidney function. - Avoid in existing hyperkalemia: do not administer if serum potassium is already elevated. - Use caution with ACE inhibitors or ARBs: concurrent use may increase potassium levels. - Perform ECG monitoring: observe cardiac rhythm in patients at risk for arrhythmias. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Potassium chloride may interact with several medicines, altering potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: can cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium accumulation. - Trimethoprim‑sulfamethoxazole: may raise serum potassium levels.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can affect digoxin toxicity. - Insulin: insulin drives potassium into cells, potentially causing fluctuations. - NSAIDs: may reduce renal potassium excretion, enhancing hyperkalemia risk.